|
LMLN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37141425887921E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.10180000257554E-08 |
| Normal-vs-Stage2 |
1.623840E-02 |
| Normal-vs-Stage3 |
4.967900E-02 |
| Normal-vs-Stage4 |
2.600800E-01 |
| Stage1-vs-Stage2 |
8.521000E-01 |
| Stage1-vs-Stage3 |
4.080400E-01 |
| Stage1-vs-Stage4 |
3.440600E-01 |
| Stage2-vs-Stage3 |
4.570000E-01 |
| Stage2-vs-Stage4 |
3.355800E-01 |
| Stage3-vs-Stage4 |
7.009000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25250032567692E-10 |
| Normal-vs-AfricanAmerican |
7.94710000000531E-05 |
| Normal-vs-Asian |
4.175800E-01 |
| Caucasian-vs-AfricanAmerican |
3.852600E-01 |
| Caucasian-vs-Asian |
4.220400E-01 |
| AfricanAmerican-vs-Asian |
5.137200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0323000494169E-10 |
| Normal-vs-Female |
5.27429999674922E-08 |
| Male-vs-Female |
2.628400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.898900E-03 |
| Normal-vs-Extreme_Weight |
7.407200E-04 |
| Normal-vs-Obese |
1.24069999996035E-06 |
| Normal-vs-Extreme_Obese |
6.258000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.337200E-01 |
| Normal_Weight-vs-Obese |
9.813800E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.317600E-01 |
| Extreme_Weight-vs-Obese |
1.010240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.532200E-01 |
| Obese-vs-Extreme_Obese |
5.262200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.838200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.00381941542582E-12 |
| Normal-vs-Age(61-80Yrs) |
2.14310000001827E-06 |
| Normal-vs-Age(81-100Yrs) |
5.162800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.726000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.986000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.471700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.276200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.563600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.603600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55351295663786E-15 |
| Normal-VS-Type2 PRCC |
8.017900E-02 |
| Normal-VS-KIRP CIMP |
2.910000E-01 |
| Normal-VS-Unclassified PRCC |
1.401900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.94283999999101E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.858300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.338600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.299000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.628400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.010200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.861600E-03 |
| Normal-vs-N1 |
4.922000E-02 |
| Normal-vs-N2 |
2.061400E-01 |
| N0-vs-N1 |
7.411200E-01 |
| N0-vs-N2 |
5.883000E-01 |
| N1-vs-N2 |
7.825600E-01 |
|
|
